MARINUS PHARMACEUTICALS INC's ticker is and the CUSIP is 56854Q200. A total of 109 filers reported holding MARINUS PHARMACEUTICALS INC in Q2 2023. The put-call ratio across all filers is 0.17 and the average weighting 0.3%.
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Lion Point Capital, LP | 2,257,521 | $24,516,678 | 11.08% |
| Ally Bridge Group (NY) LLC | 390,418 | $4,239,939 | 5.14% |
| Bleichroeder LP | 1,872,463 | $20,334,948 | 4.13% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 4,057,611 | $44,065,655 | 2.36% |
| Opaleye Management Inc. | 625,000 | $6,787,500 | 1.62% |
| Bain Capital Life Sciences Investors, LLC | 1,431,058 | $15,541,290 | 1.60% |
| Ikarian Capital, LLC | 611,932 | $6,645,582 | 1.06% |
| Logos Global Management LP | 525,000 | $5,701,500 | 0.78% |
| Sofinnova Investments, Inc. | 962,619 | $10,454,042 | 0.68% |
| GMT CAPITAL CORP | 1,554,995 | $16,887,246 | 0.64% |